Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RegenMed, officially Lake Superior Centre for Regenerative Medicine, is a Canadian not-for-profit regenerative medicine and tissue-processing organization based in Thunder Bay, Ontario. The organization processes and distributes human allograft tissues for orthopaedic and sports medicine applications across Canada, including tendons, ligaments, bone particulates, structural grafts, and fascia membranes. RegenMed also commercializes DermGEN, an acellular dermal matrix for wound care that is promoted for chronic diabetic foot ulcers and other acute and chronic wound applications. The organization operates under a cost-recovery model, is certified by Health Canada, and is accredited by the American Association of Tissue Banks. Its business combines tissue banking, allograft manufacturing, and regenerative wound-healing products rather than a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RegenMed.